JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5801
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$286M
| $38.2K | ﹤0.01% |
828
+271
| +49% | +$11.9K |
2022 Q4
5 quarters
|
|
5802
TELA Bio
TELA
$51.5M
| $37.9K | ﹤0.01% |
6,683
-4,298
| -39% | -$28.3K |
2022 Q3
6 quarters
|
|
5803
OppFi
OPFI
$515M
| $37.9K | ﹤0.01% |
15,143
+8,169
| +117% | +$27.8K |
2021 Q3
10 quarters
|
|
5804
Westlake Chemical Partners
WLKP
$755M
| $37.9K | ﹤0.01% |
1,705
-416
| -20% | -$9.34K |
2021 Q3
10 quarters
|
|
5805
Invesco Semiconductors ETF
PSI
$3.04B
| $37.8K | ﹤0.01% |
669
-2,918
| -81% | -$152K |
2022 Q2
7 quarters
|
|
5806
Zevia
ZVIA
$87.3M
| $37.7K | ﹤0.01% |
32,250
+5,510
| +21% | +$8.5K |
2023 Q2
3 quarters
|
|
|
CCRD
5807
DELISTED
CoreCard
CCRD
| $37.6K | ﹤0.01% |
3,406
-1,895
| -36% | -$22.5K |
2019 Q2
19 quarters
|
|
|
LENZ
5808
LENZ Therapeutics
LENZ
$113M
| $37.6K | ﹤0.01% |
1,682
-913
| -35% | -$19K |
2021 Q3
10 quarters
|
|
5809
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.32B
| $37.5K | ﹤0.01% |
957
-2,438
| -72% | -$88.9K |
2023 Q1
4 quarters
|
|
|
RBOT
5810
DELISTED
Vicarious Surgical
RBOT
| $37.4K | ﹤0.01% |
4,135
+1,304
| +46% | +$15.6K |
2021 Q4
9 quarters
|
|
5811
Birkenstock
BIRK
$5.58B
| $37.3K | ﹤0.01% |
789
+439
| +125% | +$21K |
2023 Q4
1 quarter
|
|
|
OMGA
5812
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $36.9K | ﹤0.01% |
10,098
-5,699
| -36% | -$21.9K |
2021 Q3
10 quarters
|
|
|
ARC
5813
DELISTED
ARC Document Solutions, Inc.
ARC
| $36.8K | ﹤0.01% |
13,283
-18,480
| -58% | -$52.2K |
2023 Q1
4 quarters
|
|
|
SRG
5814
CALL
Seritage Growth Properties
SRG
$98.6M
| $36.7K | ﹤0.01% |
+3,800
| New | +$35.7K |
2024 Q1
0 quarters
|
|
|
BKN
5815
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
| $36.6K | ﹤0.01% |
2,951
-5,254
| -64% | -$63.1K |
2022 Q4
5 quarters
|
|
5816
PUT
Robinhood
HOOD
$103B
| $36.2K | ﹤0.01% |
+1,800
| New | +$25.2K |
2024 Q1
0 quarters
|
|
5817
Nuveen Virginia Quality Municipal Income Fund
NPV
$182M
| $36.1K | ﹤0.01% |
+3,265
| New | +$35.6K |
2024 Q1
0 quarters
|
|
5818
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.25B
| $36K | ﹤0.01% |
2,960
+2,339
| +377% | +$27.8K |
2023 Q4
1 quarter
|
|
|
OCEA
5819
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $35.9K | ﹤0.01% |
9,483
+741
| +8% | +$1.39K |
2023 Q2
3 quarters
|
|
|
MVT
5820
DELISTED
BlackRock MuniVest Fund II
MVT
| $35.9K | ﹤0.01% |
3,286
+3,180
| +3,000% | +$34.3K |
2023 Q2
3 quarters
|
|
5821
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$414M
| $35.8K | ﹤0.01% |
394
| – | – |
2023 Q4
1 quarter
|
|
5822
SunCar Technology Group
SDA
$41.6M
| $35.8K | ﹤0.01% |
+4,762
| New | +$35K |
2024 Q1
0 quarters
|
|
5823
Cenntro
CENN
$9.31M
| $35.7K | ﹤0.01% |
419
+418
| +41,800% | +$33.4K |
2022 Q1
8 quarters
|
|
|
MQT
5824
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $35.6K | ﹤0.01% |
3,391
-15,469
| -82% | -$161K |
2023 Q3
2 quarters
|
|
|
NBH
5825
Neuberger Municipal Fund Inc
NBH
$266M
| $35.6K | ﹤0.01% |
3,399
-5,883
| -63% | -$61K |
2023 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.